Join Us Next Year in New Orleans!
Join Us Next Year
in New Orleans!

March 6-9, 2014

National PharmFree Week

National PharmFree Week
April 8-12, 2013

PharmFree Scorecard Released
Majority of U.S. Medical Schools Have Strong Pharmaceutical Conflict-of-Interest Policies: AMSA Survey to Review Policies at U.S. Teaching Hospitals Next

National PharmFree Week (NPFW) is an annual event to highlight the importance of putting patients first by addressing conflicts of interest and encouraging evidence rather than marketing-based education. NPFW aims to focus the attention of medical, premedical, and allied health students on the importance of understanding the impact and control of financial and professional conflicts of interest in education, research, and patient care. AMSA has put together a wide variety of student and institutional projects for education and policy change which you can learn more about below or by visiting www.pharmfree.org.

This programming was made possible by a grant from the state Attorney General Consumer and Prescriber Education Grant Program which is funded by the multi-state settlement of consumer fraud claims regarding the marketing of the prescription drug Neurontin. Presented by: AMSA’s PharmFree Campaign

National PharmFree Week 2013

April 9, 2013: Launch of the 2013 AMSA PharmFree Scorecard 12-1pm (EST)

Join National Physicians Alliance & AMSA Online Webcast or Live In-Person

National Grand Rounds
The AMSA Scorecard: The State of Medical School Conflict-of-Interest Policies and Cultivating a New Era of Effective Change

Georgetown University Medical Center, Med-Dental Building, Room SW107,
3900 Reservoir Road, NWSE408, Washington, DC 20057

Speakers:

Reshma Ramachandran, Pharmfree Fellow
American Medical Student Association

Ms. Reshma Ramachandran is a rising fourth year medical student at Warren Alpert School of Medicine at Brown University.  She is currently serving as the AMSA PharmFree Fellow, overseeing the PharmFree Campaign, which works with medical schools to ensure evidence-based rather than marketing-based medical education and empowers medical students to drive institutional change to mitigate conflicts of interest. She will be discussing the 2012-2013 results of the AMSA PharmFree Scorecard, a tool established in 2007 to grade medical schools on their conflict of interest policies. Now in its fifth iteration, the Scorecard encourages institutions to adopt strong and effective conflict of interest policies.

Daniel Carlat, MD
Director of the Pew Prescription Project

Dr. Daniel Carlat oversees the Pew Prescription Project, which seeks to ensure transparency in physician-industry relationships and promotes policies to reduce or manage conflicts of interest that could affect patient care.  He will provide an update on the rationale for upcoming changes to the 2014 AMSA Scorecard and offer institutions the opportunity to learn how best to prepare.

RSVP to attend this live event in-person
Register to participate in this live online webcast

Refreshments Included

For more information please contact: Ann Woloson, NPA Director of Education at ann.woloson@npalliance.net

This event offered as part of the Partnership to Advance Conflict-free Medical Education. This partnership and related materials were made possible by a grant from the state Attorney General Consumer and Prescriber Education Grant Program which is funded by the multi-state settlement of consumer fraud claims regarding the marketing of the prescription drug Neurontin. Learn more at www.npalliance.org/conflict-free

April 10, 2013: National Opt Out Day

On April 10, AMSA is asking its graduating fourth year members to tell the American Medical Association (AMA) that they are opting out of the AMA Physician Masterfile! As physicians who strive to practice evidence-based medicine, we do not want our personal and prescribing information sold to the pharmaceutical and medical device industries.

The AMA Physician Masterfile was established by the AMA in 1906 as a record keeping device supporting membership and mailing activities. The Physician Masterfile includes current and historical data for more than 1.4 million physicians, residents and medical students in the United States. Today, sales of the AMA Physician Masterfile totals more than $40 million per year and over 20 percent of their annual revenue.

Want to do more? Write a letter to the editor and share it with your local newspaper.

April 11, 2013: Webinar: Miller School of Medicine AMSA Scorecard Experience 12-1pm (EST)

Dr. Laurence GardnerCome hear about how the AMSA Scorecard spurred the administration and students at University of Miami Miller School of Medicine to improve their conflict of interest policies as well as the barriers both current and past to implementing change.

Executive Dean of Education and Policy Dr. Laurence Gardner will be presenting.

Click here to watch online: Microgrants are available for students who wish to host viewing parties of either the live or recorded event.

For More Information

If you are interested in learning more about these projects, obtaining additional materials, or just want to share great events you have planned, please contact PharmFree via pharmfree.chair@amsa.org.

Work Around Your Schedule

National PharmFree Week dates not working for your school?
We highly encourage participation by shifting the dates to accommodate your schedule. Please feel free to continue using AMSA materials or to reach out for any support you may need.

Resources

View the PharmFree Initiatives

AMSA PharmFree Scorecard
The PharmFree Scorecard evaluates and grades the conflict-of-interest policies at every US medical school in a variety of domains. See how your school fared and areas improvements can be made. How does your school compare? Present your Dean and classmates the results of your school's evaluation by the 2011-2012 AMSA PharmFree Scorecard.

Lecture Disclosure
2nd Slide Campaign - AMSA has developed a project to advocate for schools to develop clear guidelines for faculty disclosure to students. In the last lecture you attended did your teacher disclose relevant relationships with industry? It's standard practice in research conferences and continuing medical education to disclose conflicts of interest. This professional duty should be incorporated into medical schools.

PharmFree Curriculum
AMSA has has developed a Model PharmFree Curriculum for teaching about drug development, marketing and conflict of interest. PharmFree is also currently developing resources to assist faculty and staff looking to make these changes at their schools, including a menu of ready-made lectures/slides and other materials, as well as a list of faculty across the country who are willing to consult on curricular development.

Policy Change at Your School
It is not often that students have the opportunity to initiate such large policy reform in their schools and medical centers. Due to recent research, media attention, and discussions in academic medicine, the issue of conflict of interest and industry-education interaction has reached a tipping point. At many schools, leadership will need a little push from students to set reforms in motion. Hear student stories of change and access a guide to engaging your school leadership in policy reforms.

Access to Medicines
PharmFree seeks to educate medical students on the the issue of access to medicines. Specifically, AMSA seeks to connect the market-driven practices of pharmaceutical companies to both domestic issues (conflicts of interest, marketing) and global issues (access to medicines, neglected disease research). Visit pharmfree.org/access for project ideas.